Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Comprehensive review of emerging anti-myeloma therapies

Home/Research, Supplements/Drugs, Therapy/Comprehensive review of emerging anti-myeloma therapies

Comprehensive review of emerging anti-myeloma therapies

I thought you should read the latest report on the state of multiple myeloma I found earlier this week in a publication called the Oncology Report.  Here is how the article opens:

Novel Therapies Put Multiple Myeloma ‘On the Ropes’

By: SUSAN LONDON,  Oncology Report Digital Network

SAN FRANCISCO – A sweep of new agents are poised to deliver what could be a knock-out blow to multiple myeloma, according to the director of the myeloma program at the University of California, San Francisco.

Dr. Jeffrey Wolf

Some are second- or third-generation agents in a mainstay class that appear to have less toxicity than and/or overcome resistance to their predecessors, Dr. Jeffrey L. Wolf said at the annual Oncology Congress here. Others come from classes not previously used in this disease.

“There is a rush to develop new drugs in myeloma,” Dr. Wolf told attendees. “We [understand] some mechanisms that the disease seems to favor, so we can interfere with those.”

The prospects, in turn, are excellent: “We have made such tremendous headway in myeloma, except for those exceptional cases with 17p deletions and some other adverse prognostic features,” he said. “As a disease, it seems to be on the ropes.”

While I feel Dr. Wolf’s assessment that myeloma “seems to be on the ropes,” is a bit optimistic, the article itself does a fine job of outlining emerging anti-myeloma therapies.

Go to:  Exciting new developments in multiple myeloma therapies to access the comprehensive list.

It is definitely worth a look–and cause for optimism.

Feel good and keep smiling!  Pat